Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 2, 1996, Pages 304-309

  Margaglione, Maurizio ^a   Celentano, Egidio ^a   Grandone, Elvira ^a   Vecchione, Gennaro ^a   Cappucci, Giuseppe ^a   Giuliani, Nicola ^a   Colaizzo, Donatella ^a   Panico, Salvatore ^a   Mancini, Francesco P ^a   Di Minno, Giovanni ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Clinica Medica   (Italy)

Author keywords

ACE genotype; family history; fibrinolytic variables; risk factor interaction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; FIBRINOLYSIS; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 9044232866     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.2.304     Document Type: Article

References (39)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 1988;58:249-261.
3. Steinherg D. The cholesterol controversy is over: why did it take so long? Circulation. 1989;80:1070-1078.
4. De Witt SG. Cholesterol revisited: molecule, medicine, and media. Arteriosclerosis. 1989;9:430-438.
5. Fuster V, Badimon L, Badimon J, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
6. Ridker PM, Hennekens CH. Hemostatic risk factors for coronary heart disease. Circulation. 1991;83:1098-1100.
7. Heller HF, Chinn S, Tunstall Pedoe HD, Rose G. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J. (Clin Res Ed) 1984;288:1409-1411.
8. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic disease. JAMA. 1987;257:2318-2324.
9. Cambien F, Soubrier F. The angiotensin-converting enzyme: molecular biology and implication of the gene polymorphism in cardiovascular diseases. In: Larg JH, Brenner BM, eds. Hypertension, Pathophysiology and Management. 2nd ed. New York, NY: Raven Press Ltd; 1995:1667-1682.
10. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounts for half of the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
11. Coxterousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in the human circulating mononuclear cells: genetic polymorphism of expression in T lymphocytes. Biochem J. 1993;290:33-40.
12. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JN, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
13. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Amouyel P, Cambien F. Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet. 1993;341:991-992.
14. Badenhop RF, Wang XL, Wilken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation. 1995;91:1655-1658.
15. Ruiz J, Blanché H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA. 1994;91:3662-3665.
16. Ridker PM, Hennekens CH, Stampfer MJ, Manson J, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet. 1994,343:940-943.
17. Margaglione M, Di Minno G, Grandone E, Celentano E, Vecchione G, Cappucci G, Mancini FP, Postiglione A, Panico S, Mancini M. Plasma lipoprotein (a) levels in subjects attending a metabolic ward: discrimination between individuals with and without a history of history of ischemic stroke. Arterioscler Thromb Vasc Biol. 1996;16:120-128.
18. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: evidence of a potential interaction between the renin-angiotensin system and fibrinoiytic function. Circulation. 1993;87:1969-1973.
19. Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, Giordano M, Grilli M, Simone P, Fusilli S, Panico S, Mancini M. Raised plasma fibrinogen concentrations in subjects attending a metabolic ward: relation to family history and vascular risk factors. Thromb Haemost. 1995;73:579-583.
20. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 1976;3:2303.
21. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (Dipeptyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
22. Saiki RH, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988;239:489-491.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989.
24. Norusis MJ. SPSS/PC +V2.0 Base Manual. Chicago, Ill: SPSS Inc Publisher; 1988.
25. Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene: two alternative promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem. 1991;266:15377-15383.
26. Mattei MG, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F. Angiotensin converting enzyme gene is on chromosome 17. Cytogen Cell Genet. 1989;51:1041.
27. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994;344:910-913.
28. Nicoloso G, Hauert J, Kruithof EKO, Van Melle G, Bachmann F. Fibrinolysis in normal subjects: comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Thromb Haemost. 1988;59:299-303.
29. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993;341:1165-1168.
30. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994;94:1085-1089.
31. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel R, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the Apo E and ACE loci. Nat Genet. 1994;6:29-32.
32. van Bockxmeer FM. ApoE and ACE genes: impact on human longevity. Nat Genet. 1994;6:4-5.
33. Ludwig E, Corneli PS, Anderson JL, Marshal HW, Lalouel JM, Ward LH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995;91:2120-2124.
34. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, La Motte F, Burig J, Hennekens CH. A prospective evaluation of angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
35. Zingone A, Dominijanni A, Mele E, Marasco O, Melina F, Minichella P, Quaresima B, Tiano MT, Gnasso A, Puija A, Perrotti N. Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet. 1994;94:207-209.
36. Bonh M, Berge KE, Bakkan A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genetics. 1993;44:298-301.
37. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection and congestive heart failure. N Engl J Med. 1991;325:293-302.
38. Pfeffer MA, Braunwald E, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-677.
39. Harrap SB. Genetics and coronary disease: beginning the long journey. Lancet. 1994;344:901-902.